C

Cibus Inc
NASDAQ:CBUS

Watchlist Manager
Cibus Inc
NASDAQ:CBUS
Watchlist
Price: 1.76 USD -2.22% Market Closed
Market Cap: $95.5m

Operating Margin

-1 898.5%
Current
Improving
by 4 973.5%
vs 3-y average of -6 872%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-1 898.5%
=
Operating Income
$-72m
/
Revenue
$3.8m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-1 898.5%
=
Operating Income
$-72m
/
Revenue
$3.8m

Peer Comparison

Country Company Market Cap Operating
Margin
US
Cibus Inc
NASDAQ:CBUS
92.5m USD
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
393.1B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
185.9B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
172.7B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.7B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.5B USD
Loading...
AU
CSL Ltd
ASX:CSL
86.9B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.4B EUR
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...

Market Distribution

Lower than 95% of companies in the United States of America
Percentile
5th
Based on 14 112 companies
5th percentile
-1 898.5%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Cibus Inc
Glance View

Market Cap
95.5m USD
Industry
Biotechnology

Cibus, Inc. engages in the research and development of plant traits to seed companies for royalties. The company is headquartered in San Diego, California and currently employs 228 full-time employees. The company went IPO on 2017-07-20. The firm is engaged in developing and licensing plant traits to seed companies for royalties on seed sales. The firm is involved in gene-edited trait development, where plant traits (or specific genetic characteristics) that are indistinguishable from traits developed using traditional breeding are created using gene editing. Its patented RTDS technology platform includes the Trait Machine, which is a semi-automated stand-alone trait production facility. The Company’s Trait Machine materially changes the speed, breadth, and scale of trait development. The company is focused on the development of productivity traits and sustainable ingredients. The firm focuses on developing traits for addressing the sustainability challenges presented by climate change, disease, and pests.

CBUS Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-1 898.5%
=
Operating Income
$-72m
/
Revenue
$3.8m
What is Cibus Inc's current Operating Margin?

The current Operating Margin for Cibus Inc is -1 898.5%, which is above its 3-year median of -6 872%.

How has Operating Margin changed over time?

Over the last 3 years, Cibus Inc’s Operating Margin has decreased from -1 257.1% to -1 898.5%. During this period, it reached a low of -14 279.3% on Mar 31, 2024 and a high of -1 257.1% on Sep 30, 2022.

Back to Top